2.36
price down icon3.67%   -0.09
 
loading
Alzamend Neuro Inc stock is traded at $2.36, with a volume of 38,847. It is down -3.67% in the last 24 hours and down -2.07% over the past month. Alzamend Neuro Inc is an early clinical-stage biopharmaceutical company. It is focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders, including Alzheimer's. Its mission is to develop and market safe and effective treatments. The company's pipeline consists of two novel therapeutic drug candidates, AL001 - a patented ionic cocrystal technology delivering lithium via a therapeutic combination of lithium, proline and salicylate, and AL002 - a patented method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine that seeks to restore the ability of a patient's immunological system to combat Alzheimer's.
See More
Previous Close:
$2.45
Open:
$2.37
24h Volume:
38,847
Relative Volume:
0.32
Market Cap:
$7.41M
Revenue:
-
Net Income/Loss:
$-6.24M
P/E Ratio:
-0.4225
EPS:
-5.5853
Net Cash Flow:
$-8.09M
1W Performance:
-1.67%
1M Performance:
-2.07%
6M Performance:
-60.39%
1Y Performance:
-83.91%
1-Day Range:
Value
$2.36
$2.46
1-Week Range:
Value
$2.27
$2.5562
52-Week Range:
Value
$2.06
$15.21

Alzamend Neuro Inc Stock (ALZN) Company Profile

Name
Name
Alzamend Neuro Inc
Name
Phone
844-722-6333
Name
Address
3500 LENOX RD. NE, ATLANTA
Name
Employee
7
Name
Twitter
Name
Next Earnings Date
2024-09-12
Name
Latest SEC Filings
Name
ALZN's Discussions on Twitter

Compare ALZN with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
ALZN
Alzamend Neuro Inc
2.36 9.31M 0 -6.24M -8.09M -5.5853
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
422.39 107.73B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
654.48 62.04B 14.21B 4.46B 3.56B 39.69
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
475.91 62.73B 2.46B -319.09M -52.09M -2.4669
Biotechnology icon
ARGX
Argen X Se Adr
836.39 51.09B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
165.29 34.67B 398.11M -1.03B -868.57M -5.7032

Alzamend Neuro Inc Stock (ALZN) Upgrades & Downgrades

Date Action Analyst Rating Change
Oct-01-21 Initiated Ascendiant Capital Markets Buy

Alzamend Neuro Inc Stock (ALZN) Latest News

pulisher
01:07 AM

Predicting Alzamend Neuro Inc. trend using moving averagesQuarterly Trade Review & Accurate Technical Buy Alerts - newser.com

01:07 AM
pulisher
12:43 PM

Will Alzamend Neuro Inc. stock pay special dividendsEarnings Recap Summary & Reliable Price Action Trade Plans - newser.com

12:43 PM
pulisher
12:28 PM

Alzamend Neuro Inc. stock trend outlook and recovery path2025 Fundamental Recap & Community Driven Trade Alerts - newser.com

12:28 PM
pulisher
Oct 28, 2025

Is Alzamend Neuro Inc. stock cheap compared to fundamentalsMarket Growth Review & Free Fast Gain Swing Trade Alerts - newser.com

Oct 28, 2025
pulisher
Oct 28, 2025

How currency fluctuations impact Alzamend Neuro Inc. stockTrend Reversal & Reliable Trade Execution Plans - newser.com

Oct 28, 2025
pulisher
Oct 28, 2025

Will Alzamend Neuro Inc. stock outperform growth indexesEarnings Recap Report & AI Enhanced Trading Signals - Fundação Cultural do Pará

Oct 28, 2025
pulisher
Oct 28, 2025

Why Alzamend Neuro Inc. stock could rally in 2025Market Risk Summary & Community Supported Trade Ideas - Fundação Cultural do Pará

Oct 28, 2025
pulisher
Oct 28, 2025

Will Alzamend Neuro Inc. stock remain a Wall Street favoriteTrade Volume Summary & High Conviction Investment Ideas - Fundação Cultural do Pará

Oct 28, 2025
pulisher
Oct 28, 2025

What earnings revisions data tells us about Alzamend Neuro Inc.2025 Market Overview & Technical Pattern Based Signals - newser.com

Oct 28, 2025
pulisher
Oct 28, 2025

Will Alzamend Neuro Inc. stock go up soonJuly 2025 EndofMonth & Fast Momentum Entry Tips - newser.com

Oct 28, 2025
pulisher
Oct 28, 2025

Is Alzamend Neuro Inc. stock recession proofEarnings Risk Summary & Community Consensus Picks - newser.com

Oct 28, 2025
pulisher
Oct 28, 2025

Will Alzamend Neuro Inc. stock rally after Fed decisionsJuly 2025 Earnings & Stepwise Swing Trade Plans - newser.com

Oct 28, 2025
pulisher
Oct 28, 2025

Can Alzamend Neuro Inc. stock outperform in 2025 bull marketWeekly Investment Recap & Smart Investment Allocation Tips - newser.com

Oct 28, 2025
pulisher
Oct 28, 2025

Historical volatility pattern of Alzamend Neuro Inc. visualizedEarnings Recap Summary & Expert Verified Stock Movement Alerts - newser.com

Oct 28, 2025
pulisher
Oct 28, 2025

Multi asset correlation models including Alzamend Neuro Inc.July 2025 Trade Ideas & Daily Stock Momentum Reports - newser.com

Oct 28, 2025
pulisher
Oct 28, 2025

Why Alzamend Neuro Inc. stock attracts high net worth investorsJuly 2025 Levels & Weekly High Momentum Picks - newser.com

Oct 28, 2025
pulisher
Oct 28, 2025

Is Alzamend Neuro Inc. forming a bottoming base2025 Geopolitical Influence & Smart Money Movement Tracker - newser.com

Oct 28, 2025
pulisher
Oct 28, 2025

Is Alzamend Neuro Inc. stock supported by innovation pipelineAnalyst Downgrade & Smart Allocation Stock Tips - newser.com

Oct 28, 2025
pulisher
Oct 28, 2025

Will Alzamend Neuro Inc. stock reach all time highs in 2025July 2025 Summary & Risk Managed Investment Signals - newser.com

Oct 28, 2025
pulisher
Oct 27, 2025

Can Alzamend Neuro Inc. stock resist sector downturnsWeekly Trend Summary & Risk Controlled Daily Trade Plans - newser.com

Oct 27, 2025
pulisher
Oct 27, 2025

What to do if you’re stuck in Alzamend Neuro Inc.Entry Point & Low Risk Entry Point Tips - newser.com

Oct 27, 2025
pulisher
Oct 27, 2025

Chart based exit strategy for Alzamend Neuro Inc.Weekly Loss Report & Precise Swing Trade Entry Alerts - newser.com

Oct 27, 2025

Alzamend Neuro Inc Stock (ALZN) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$36.41
price down icon 2.28%
$91.65
price down icon 1.54%
$29.13
price up icon 0.34%
$105.03
price down icon 0.96%
biotechnology ONC
$316.85
price up icon 0.45%
$165.29
price up icon 0.77%
Cap:     |  Volume (24h):